Claritev Net Income
| CTEV Stock | 16.91 2.48 17.19% |
As of the 4th of March, Claritev shows the mean deviation of 5.25, and Risk Adjusted Performance of (0.11). Claritev technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Claritev risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Claritev is priced correctly, providing market reflects its regular price of 16.91 per share. Given that Claritev has information ratio of (0.17), we suggest you to validate Claritev's prevailing market performance to make sure the company can sustain itself at a future point.
Claritev Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 5.1017 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -284.3 M | -298.5 M | |
| Net Loss | -1.5 B | -1.4 B | |
| Net Loss | (17.30) | (18.16) | |
| Net Income Per E B T | 0.76 | 0.97 |
Claritev | Net Income | Build AI portfolio with Claritev Stock |
The evolution of Net Income for Claritev provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Claritev compares to historical norms and industry peers.
Latest Claritev's Net Income Growth Pattern
Below is the plot of the Net Income of Claritev over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Claritev financial statement analysis. It represents the amount of money remaining after all of Claritev operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Claritev's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Claritev's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (284.28 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Claritev Net Income Regression Statistics
| Arithmetic Mean | (175,057,947) | |
| Geometric Mean | 82,827,979 | |
| Coefficient Of Variation | (246.84) | |
| Mean Deviation | 287,858,278 | |
| Median | 36,223,000 | |
| Standard Deviation | 432,120,712 | |
| Sample Variance | 186728.3T | |
| Range | 1.7B | |
| R-Value | (0.55) | |
| Mean Square Error | 139989.4T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | (46,647,715) | |
| Total Sum of Squares | 2987653T |
Claritev Net Income History
Other Fundumenentals of Claritev
Claritev Net Income component correlations
Claritev Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Claritev is extremely important. It helps to project a fair market value of Claritev Stock properly, considering its historical fundamentals such as Net Income. Since Claritev's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Claritev's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Claritev's interrelated accounts and indicators.
Click cells to compare fundamentals
What growth prospects exist in Health Care Equipment & Supplies sector? Can Claritev capture new markets? Factors like these will boost the valuation of Claritev. Projected growth potential of Claritev fundamentally drives upward valuation adjustments. Valuation analysis balances hard financial data with qualitative growth assessments. While each Claritev valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Earnings Share (17.30) | Revenue Per Share | Quarterly Revenue Growth 0.062 | Return On Assets | Return On Equity |
Investors evaluate Claritev using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Claritev's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Claritev's market price to deviate significantly from intrinsic value.
It's important to distinguish between Claritev's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Claritev should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Claritev's market price signifies the transaction level at which participants voluntarily complete trades.
Claritev 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Claritev's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Claritev.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Claritev on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Claritev or generate 0.0% return on investment in Claritev over 90 days. Claritev is related to or competes with Goodrx Holdings, Opko Health, Evolent Health, Integra LifeSciences, Sana Biotechnology, Iradimed, and Axogen. Claritev is entity of United States. It is traded as Stock on NYSE exchange. More
Claritev Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Claritev's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Claritev upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 56.65 | |||
| Value At Risk | (12.87) | |||
| Potential Upside | 10.44 |
Claritev Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Claritev's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Claritev's standard deviation. In reality, there are many statistical measures that can use Claritev historical prices to predict the future Claritev's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (1.70) | |||
| Treynor Ratio | 0.6683 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Claritev's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Claritev March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 0.6783 | |||
| Mean Deviation | 5.25 | |||
| Coefficient Of Variation | (614.98) | |||
| Standard Deviation | 8.1 | |||
| Variance | 65.69 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (1.70) | |||
| Treynor Ratio | 0.6683 | |||
| Maximum Drawdown | 56.65 | |||
| Value At Risk | (12.87) | |||
| Potential Upside | 10.44 | |||
| Skewness | (1.80) | |||
| Kurtosis | 8.97 |
Claritev Backtested Returns
Claritev secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1 % return per unit of standard deviation over the last 3 months. Claritev exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Claritev's risk adjusted performance of (0.11), and Mean Deviation of 5.25 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.99, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Claritev are expected to decrease by larger amounts. On the other hand, during market turmoil, Claritev is expected to outperform it. At this point, Claritev has a negative expected return of -0.82%. Please make sure to confirm Claritev's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Claritev performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Claritev has average predictability. Overlapping area represents the amount of predictability between Claritev time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Claritev price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Claritev price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 25.23 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Claritev Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Claritev reported net income of (284.28 Million). This is much lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Claritev Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Claritev's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Claritev could also be used in its relative valuation, which is a method of valuing Claritev by comparing valuation metrics of similar companies.Claritev is currently under evaluation in net income category among its peers.
Claritev Current Valuation Drivers
We derive many important indicators used in calculating different scores of Claritev from analyzing Claritev's financial statements. These drivers represent accounts that assess Claritev's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Claritev's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 475.2M | 466.4M | 470.9M | 702.6M | 632.3M | 393.4M | |
| Enterprise Value | 5.2B | 4.9B | 5.0B | 5.3B | 4.8B | 4.0B |
Claritev ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Claritev's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Claritev's managers, analysts, and investors.Environmental | Governance | Social |
Claritev Institutional Holders
Institutional Holdings refers to the ownership stake in Claritev that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Claritev's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Claritev's value.| Shares | Topline Capital Management Llc | 2025-09-30 | 201.8 K | Geode Capital Management, Llc | 2025-09-30 | 174.9 K | State Street Corp | 2025-09-30 | 155.3 K | Nomura Holdings Inc | 2025-09-30 | 147.3 K | Third Point, Llc | 2025-12-31 | 145 K | Rbf Llc | 2025-12-31 | 134.2 K | Morgan Stanley - Brokerage Accounts | 2025-09-30 | 99.3 K | Oak Hill Advisors Lp | 2025-12-31 | 91.8 K | The Goldman Sachs Group Inc | 2025-09-30 | 84.5 K | H&f Corporate Investors Viii, Ltd. | 2025-09-30 | 5.4 M | Australiansuper Pty Ltd | 2025-09-30 | 3.2 M |
Claritev Fundamentals
| Return On Equity | -6.46 | ||||
| Return On Asset | 0.0112 | ||||
| Profit Margin | (0.29) % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 4.85 B | ||||
| Shares Outstanding | 16.53 M | ||||
| Shares Owned By Insiders | 6.76 % | ||||
| Shares Owned By Institutions | 93.93 % | ||||
| Number Of Shares Shorted | 965.87 K | ||||
| Price To Book | 43.86 X | ||||
| Price To Sales | 0.29 X | ||||
| Revenue | 965.41 M | ||||
| Gross Profit | 712 M | ||||
| EBITDA | 475.44 M | ||||
| Net Income | (284.28 M) | ||||
| Total Debt | 4.63 B | ||||
| Book Value Per Share | (10.51) X | ||||
| Cash Flow From Operations | 117.32 M | ||||
| Short Ratio | 6.87 X | ||||
| Earnings Per Share | (17.30) X | ||||
| Target Price | 44.75 | ||||
| Number Of Employees | 3 K | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 279.45 M | ||||
| Total Asset | 4.89 B | ||||
| Retained Earnings | (2.43 B) | ||||
| Working Capital | (38.27 M) | ||||
| Net Asset | 4.89 B |
About Claritev Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Claritev's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Claritev using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Claritev based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Claritev Stock Analysis
When running Claritev's price analysis, check to measure Claritev's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Claritev is operating at the current time. Most of Claritev's value examination focuses on studying past and present price action to predict the probability of Claritev's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Claritev's price. Additionally, you may evaluate how the addition of Claritev to your portfolios can decrease your overall portfolio volatility.